Our study demonstrated that the TLR4/NF-κB signalling pathway was an important signalling cascade involved in BBB integrity and melatonin might be a new candidate as a therapeutic agent for protecting the CNS neurological diseases characterized by a compromised BBB. The gene discussed is TLR4; the disease is nervous system disorder.